Keane Raymond T 4
4 · ARIAD PHARMACEUTICALS INC · Filed Apr 3, 2013
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Exercise/Conversion
Common Stock
2013-04-01+5,166→ 56,679 total - Sale
Common Stock
2013-04-02$18.05/sh−2,583$46,625→ 54,096 total - Exercise/Conversion
Restricted Stock Units
2013-04-01−5,166→ 0 total→ Common Stock (5,166 underlying)
Footnotes (4)
- [F1]Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011.
- [F2]Represents shares withheld to satisfy withholding tax requirements.
- [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The restricted stock units vested on April 1, 2013.